Nottingham Breast Pathology Masterclass Faculty (2018)
Professor Ian Ellis
Professor Jelle Wesseling
Professor Sarah Pinder
Professor Emad Rakha
Dr Abeer Shabaan
Dr Andrew HS Lee
Dr Vishaka Sovani
Dr Somaia Elshikh
Professor Ian Ellis – Professor of Cancer Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham University, Honorary Consultant Pathologist Nottingham City Hospital, founding member of the faculty of the Nottingham International Breast Education Centre. He has been Specialty Advisor of The Royal College of Pathologists, and is Chairman of the UK National Coordinating Committee for Breast Pathology. He has acted as an advisor to the Department of Health London, the Union for International Cancer Control, the World Health Organization and the International Agency for Research on Cancer. He is a founder of PathLore specialist pathology and reference laboratory, and Medical Director for Source Bioscience plc. Dr. Ellis has authored over 500 peer-reviewed scientific publications, and chapters in medical and pathology textbooks.
Dr. Jelle Wesseling – Senior Group Leader & Consultant Breast Pathologist, The Netherlands Cancer Institute. Jelle has gained MSc in Medicine in 1987 and cum laude MSc in Chemistry in 1991, both at the University of Groningen, the Netherlands. He received his PhD in molecular pathology at the Netherlands Cancer Institute in 1997. He obtained his MD cum laude at the Free University Medical Centre in Amsterdam in 1999. He was trained as a pathologist at the University Medical Centre Groningen. He became a consultant breast pathologist and group leader in 2006. He has the ideal skill-set and expertise to achieve the full transition from bench-to-bedside. Jelle focuses on finding biomarkers distinguishing low and high DCIS. His research aims attention at optimizing personalized diagnosis and treatment of each breast cancer patient by searching for novel prognostic and predictive biomarkers using a combination of pathology, molecular analyses, and epidemiology. Ultimately, he aims at answering the questions which breast cancer patient needs what type of treatment for how much benefit. He is member of various breast cancer working committees globally.
Professor Emad Rakha Professor and Honorary Consultant Pathologist Department of Histopathology, The University of Nottingham and Nottingham University Hospitals NHS Trust. Dr Rakha has authored over 250 peer-reviewed scientific publications, in addition to more than 25 chapters in medical and pathology textbooks in the field of breast disease. He is member of the National Co-ordinating Committee for Breast Pathology (BIG18), UK PathSoc Committee, International society of Breast Pathology Committee, Breast Cancer Now Tissue bank Access Committee, Nottingham Health Science Biobank Board and The National Cancer Research Institute (NCRI) Breast CSG and its Translational Subgroup. Professor Rakha has been reporting breast referral cases in Nottingham since 2011 and he reports private breast cases referred to Source Biosciences plc.
Professor Sarah Pinder – Professor of Breast Pathology & Head of Research Oncology King’s College London and Lead Consultant Breast Pathologist at Guy’s and St Thomas’ Hospitals. She serves on the National Cancer Intelligence Network (NCIN) Breast Reference Group, the NHS Breast Screening Programme Pathology Co-ordinating Committee, the Sloane Project (UK National DCIS audit) Steering Group and Chairs the NHS Breast Screening Programme Pathology Research Committee. Professor Pinder has published approximately 200 peer-reviewed articles, over 50 invited reviews, and approximately 50 chapters on breast diseases in medical textbooks.
Dr Andrew HS Lee – Consultant Histopathologist specialising in breast pathology at Nottingham University Hospitals. He has been a member of the National Coordinating Committee for Breast Pathology since 2006, chairing the group that organises the annual National Breast Pathology Update Courses. His research interests include core biopsy diagnosis, spindle cell and fibroepithelial lesions and prognostic factors in breast cancer including the role of inflammation.
Dr Abeer Shaaban – Consultant Breast Pathologist/ Honorary Senior Lecturer Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham. Dr Shaaban is a specialist breast pathologist and member of the International Committee of the Royal College of Pathologists and the Scientific Advisory Committee of Breast Cancer Campaign.